Otsuka Holdings Co., Ltd. (TYO:4578)
Japan flag Japan · Delayed Price · Currency is JPY
9,611.00
+267.00 (2.86%)
Feb 9, 2026, 3:30 PM JST

Revenue by Geography

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014FY 2013
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Mar '14 Mar '13
Japan Revenue
705.50B699.70B670.90B
Japan Revenue Growth
0.83%4.29%2.47%
North America Revenue
1.15T1.10T873.40B
North America Revenue Growth
5.09%25.38%27.78%
Europe Revenue
251.10B242.90B218.70B
Europe Revenue Growth
3.38%11.06%26.27%
Others Revenue
294.40B292.20B255.70B
Others Revenue Growth
0.75%14.27%12.84%
Overseas Revenue
1.70T1.63T1.35T
Overseas Revenue Growth
4.05%20.96%24.41%

Revenue

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014FY 2013
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Mar '14 Mar '13
Pharmaceuticals Revenue
1.70T1.63T1.39T
Pharmaceuticals Revenue Growth
4.12%17.10%22.26%
Nutraceuticals Revenue
561.23B557.01B483.33B
Nutraceuticals Revenue Growth
0.76%15.25%10.60%
Consumer Products Revenue
33.92B33.75B37.07B
Consumer Products Revenue Growth
0.50%-8.94%3.38%
Other Segment Revenue
110.46B110.07B107.02B
Other Segment Revenue Growth
0.35%2.85%-15.91%

Adjusted EBIT

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014FY 2013
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Mar '14 Mar '13
Pharmaceuticals Business Profit
417.76B390.61B282.09B
Pharmaceuticals Business Profit Growth
6.95%38.47%85.74%
Nutraceuticals Business Profit
62.74B64.15B60.46B
Nutraceuticals Business Profit Growth
-2.20%6.09%11.56%
Consumer Products Business Profit
24.28B23.66B18.10B
Consumer Products Business Profit Growth
2.61%30.72%153.69%
Other Segment Business Profit
7.33B6.95B3.13B
Other Segment Business Profit Growth
5.47%121.83%-65.36%
Eliminations from Business Profit
-56.05B-54.91B-51.23B

EBIT

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014FY 2013
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Mar '14 Mar '13
Pharmaceuticals Segment Profit
404.44B285.11B143.65B
Pharmaceuticals Segment Profit Growth
41.85%98.47%16.65%
Nutraceuticals Segment Profit
59.12B59.78B34.24B
Nutraceuticals Segment Profit Growth
-1.10%74.56%-39.15%
Consumer Products Segment Profit
23.57B23.00B12.14B
Consumer Products Segment Profit Growth
2.48%89.50%75.12%
Other Segment Profit
7.72B7.53B278.00M
Other Segment Profit Growth
2.56%2606.84%-97.67%
Eliminations from Segment Profit
-55.44B-51.85B-50.70B
Updated Jun 30, 2025. Data Source: Fiscal.ai.